Skip to main content
Clinical Trials/NCT03810716
NCT03810716CompletedNot Applicable

Promotion of Family Planning Methods Through an Interactive Platform Offered in Growth and Development Control Services

Universidad Peruana Cayetano Heredia2 sites in 1 country176 target enrollmentStarted: October 29, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
176
Locations
2
Primary Endpoint
Percentage of mothers who attend the family planning service

Study Overview

Brief Summary

Family planning and the use of contraceptive methods are of the main strategies to reduce maternal and perinatal morbidity and mortality, because they can prevent unplanned pregnancies, teenage pregnancies and abortions in dangerous conditions. It is also a tool that contributes to development as it improves children's health, improves access to early childhood education, empowers women and contributes to reducing poverty as it improves economic conditions.

Currently the use of modern contraceptive methods has increased worldwide, in Latin America and the Caribbean the use of modern contraceptive methods has remained at 66.07% from 2008 to 2015. However, the number of women who do not want to get pregnant and that do not use a contraceptive method is still high - 214 million women of childbearing age in developed countries.

In our country according to the ENDES 2016 survey, the number of women who used a contraceptive method decreased by 0.7 percent compared to 2012, of which 54.3 percent used some modern contraceptive method and 21.9 percent some method traditional.

The unmet demand for family planning in 2016 was 6.0%, affecting mainly women from the lowest poverty quintile (7.4%) and those living in rural areas (6.8%).

Of the women who were surveyed and did not use a contraceptive method, 80.6% did not talk about family planning either at home or in a health facility in the last 12 months. Only 16.3% of non-users were women who attended a health facility and received information on family planning.

Through this study the investigators propose the design and evaluation of an interactive platform to promote modern contraceptive methods.

Detailed Description

Sample Size: Sample size of 176 participants (interventional group=88, control group=88), it is possible to detect minimum differences of 5% to 20%.

Statistical analysis plan: The data collected will be entered into a database in Microsoft Excel, to be analyzed by the Epi Info statistical program. The qualitative variables will be analyzed by frequencies and percentages, the quantitative variables by relative risk.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 49 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Mothers of children who attend the service of growth and development who are of legal age
  • •Women who do not currently use some modern contraceptive method
  • •Women whose partners have not received voluntary surgical contraception

Exclusion Criteria

  • •Teen mothers
  • •Illiterate women
  • •Women who currently do not have a partner
  • •Women who are currently gestating

Arms & Interventions

Interactive Platform

Experimental

Tha participants in this group will see the interactive platform and answer a survey before and after the intervention. Their clinical health records will be checked one month ago.

Intervention: Interactive Platform (Device)

Control

No Intervention

The participants in this group will answer the survey. Their clinical health records will be checked one month ago.

Outcomes

Primary Outcomes

Percentage of mothers who attend the family planning service

Time Frame: one month

Percentage of women who assist to family planning service after the intervention

Secondary Outcomes

  • Percentage of mothers who initiate a contraceptive method(one month after the intervention)
  • Satisfaction of the users about the interactive platform(immediately after the intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Suzzane Minaya Romero

Principal Investigator

Universidad Peruana Cayetano Heredia

Study Sites (2)

Loading locations...

Similar Trials